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Observational Studies of Statins in Bacteremia
P. Kruger
Princess Alexandra Hospital, Brisbane, Australia
Statins have become the most widely used drugs for lowering
cholesterol with at least 15% of patients requiring admission
to hospital on established statin therapy, and this number is
growing each year. However, statins have been postulated
to have beneﬁcial effects independent of their lipid low-
ering including anti-inﬂammatory and immunomodulatory
roles. Evidence is emerging from observational studies and
basic science research that HMG Co A Reductase inhibitors
(statins) might be associated with a reduced mortality in
sepsis.
A number of observational studies have suggested that
patients on statins for heart disease are less likely to develop
infections and that their infections are less likely to be
severe or result in death. Not all studies support a beneﬁt
associated with statin therapy for patients with sepsis. Other
studies have suggested that stopping statins in patients that
present with infections (as suggested by current guidelines),
may worsen outcomes.
The desire to incorporate the ever expanding potential
of these agents into routine clinical practice for patients
with sepsis must be tempered by the potential for adverse
effects. There is a signiﬁcant body of evidence that the side
effects of statins may be more frequent and serious in the
critically ill. A variety of less well known toxicities are being
reported as these agents gain more widespread use.
This is a rapidly growing ﬁeld of fascinating experimental
biology that suggests an urgent need for the investigation
of the pharmacology and a reappraisal of the therapeutic
indications of these drugs in patients with sepsis. This may
provide new insights to the role of lipids and the endothe-
lium in the response to infection. The potential for statins as
an adjuvant therapy in sepsis is a simple, inexpensive inter-
vention that warrants further prospective investigation.
doi:10.1016/j.ijid.2008.05.057
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Parasites as host cholesterol consumers: The special case
of Toxoplasma gondii
K.A. Joiner1,∗, I. Coppens2
1 University of Arizona, Tucson, AZ, USA
2 Johns Hopkins University, Baltimore, MD, USA
Background: All protozoan parasites pathogenic for humans
are cholesterol auxotrophs and must acquire cholesterol
from the host. Deﬁning the acquisition process provides
insights into pathogenesis and avenues for therapeutic inter-
vention.
Results: The obligate intracellular protozoan parasite
Toxoplasma gondii actively invades all nucleated mam-
malian cells and resides within a parasitophorous vacuole
(PV), surrounded by a specialized membrane (PVM). From
that location, parasites acquire host cell cholesterol endo-
cytosed by the host cell LDL receptor pathway. The parasite
actively recruits host microtubules, resulting in selective
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ttraction of host endolysosomes to the PV. Microtubule-
ased invaginations of the PVM serve as conduits for
elivery of host endolysosomes within the PV, where they
re sequestered by a tubular coat. Blocking cholesterol
xit from the endolysosomes inhibits parasite growth.
holesterol transits the parasite plasma membrane in a
rotein-dependent fashion, then accumulates in the para-
ite interior, in a process augmented by the parasite Rab5.
either statins nor disruption of the host cell endoplasmic
eticulum or Golgi functions impair cholesterol delivery to
oxoplasma. With excess host fatty acids and LDL, choles-
erol is rapidly esteriﬁed by a parasite acyl-cholesterol
cyltransferase (ACAT), and accumulates in parasite lipid
odies. This process can be inhibited by selected ACAT
nhibitors, that induce parasite plasma membrane destabi-
ization and rupture. By contrast, malaria parasites residing
n a PV within hepatocytes acquire needed cholesterol from
oth host plasma LDL and the host endogenous biosyn-
hetic pathway. Pharmacological interference with the host
evalonate pathway reduces Plasmodium development in
epatocytes.
Conclusions: In combination, these results show how a
eries of unique parasite adaptations selectively drive para-
ite acquisition of cholesterol from the host cell. Depending
pon the parasite and host cell, manipulations which impair
holesterol transport to the PV, cholesterol storage within
he parasite, or host cell cholesterol synthesis, block para-
ite growth.
oi:10.1016/j.ijid.2008.05.058
odels of Tools for Optimizing Public Health Prepared-
ess: The Case of Pandemic Inﬂuenza (invited)
.001
lanning for Pandemics: Epidemiological Analysis in the
ormulation of Public Health Policy
. Anderson
Imperial College London, London, United Kingdom
any new quantitative epidemiological tools have been
eveloped in recent years to aid in the formulation of public
ealth policy and to delineate optimal control interventions
or epidemics of directly transmitted respiratory tract infec-
ions such as inﬂuenza A. The presentation will describe the
ange of methods that can be applied and their strengths and
eaknesses for different situations. Speciﬁc applications
ill focus on SARS and inﬂuenza A. The current situation
ith H5N1 will be examined and various control interven-
ions used alone or in combination will be analysed using
imulation approaches. Novel methods to meld economic
onsiderations of cost and beneﬁt with those of transmis-
ion dynamics will be introduced and used to assess current
ountry based pandemic plans. The paper will end with a dis-
ussion of the adequacy of currently published country wide
nd international plans for pandemic control with a focus
n the presence or absence of detail in these plans and the
mportance of speed of implementation and logistics.
oi:10.1016/j.ijid.2008.05.059
